Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
Preliminary results indicate that CCL11-KO mice are more susceptible to infection compared to controls, highlighting a complex role for CCL11 in balancing antiviral defense and neuro inflammation, and investigating CCL11 as a potential mediator linking peripheral respiratory infection to persistent neuroinflammation.
Abstract
Growing evidence suggests that peripheral infections contribute to neurodegenerative disease progression and cognitive impairment, yet the underlying neuro-immune mechanisms remain poorly understood.
Here, we used a mouse model of Influenza A virus (H1N1) respiratory infection to investigate immune responses in the central nervous system (CNS).
At day 6 post-infection, we observed significant increases in microglia, perivascular macrophages, monocytes, NK cells, and neutrophils, indicating infection-driven immune activation within the CNS. Strikingly, eosinophils persisted in both brain/leptomeninges and dura mater up to 7 weeks post-infection. No viral RNA was detected in the brain at any time point, whereas lung tissue harbored high viral loads, suggesting peripheral infection as the driver of neuroinflammation. Cytokine and chemokine profiling revealed persistent elevation of CCL11 in serum at both day 6 and week 7. CCL11 has been implicated in other peripheral infection related neuroinflammation, potentially contributing to myelin loss and impaired neurogenesis, although mechanisms remain unknown. To address the role of CCL11 in CNS inflammation and dysfunction in this context, we have begun characterizing CCL11 knockout (KO) mice following influenza infection. Preliminary results indicate that CCL11-KO mice are more susceptible to infection compared to controls, highlighting a complex role for CCL11 in balancing antiviral defense and neuroinflammation. Furthermore, scRNA-seq analysis of healthy mice revealed high CCL11 expression in dural sinus smooth muscle cells, leptomeningeal fibroblasts and brain pericytes suggesting that brain border cells may contribute to local regulation of immune responses after infection.
Moving forward, our goal is to investigate CCL11 as a potential mediator linking peripheral respiratory infection to persistent neuroinflammation, providing insight into mechanisms by which infections may contribute to long-term brain dysfunction.
Emerging pathogen consortia, HHMI
Neuroimmunology (NEUR)
HSV-1 encephalitis (HSE) remains a devastating viral infection of the central nervous system despite effective antiviral therapy. Increasing evidence indicates that disease outcome is not determined by viral replication alone but by how innate immunity is calibrated within the brain. Studies of host susceptibility in c...
Sheng Yang, Yang-Kun Shen, Chunfu Zheng· Current Opinion in Virology· 1 citation
Understanding neuroimmune responses during brain infections remains challenging because the site of disease (i.e., the brain) is difficult to access, immune responses within the central nervous system (CNS) are spatially and temporally compartmentalized, and peripheral immune cells have largely served as a proxy for th...
Antiretroviral therapy (ART) effectively suppresses systemic HIV replication but does not eradicate viral reservoirs in the brain, where their identity and contribution to neurological injury remain poorly defined. Using bulk, single-cell, and single-nucleus transcriptomics of postmortem human brain tissue, we identify...
C. S. Shabangu, Hong-Jie Chen, A. Manickam et al.· bioRxiv· 0 citations
Group 2 innate lymphoid cells (ILC2) are tissue-resident innate immune cells that function as critical cellular interfaces bridging the nervous and immune systems. In peripheral barrier tissues, ILC2s express a diverse repertoire of receptors for neurotransmitters and neuropeptides, enabling them to integrate neuronal...
Qiang Liu, Jie Zhou· Immunity & Inflammation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.